Annals of the New York Academy of Sciences

Cover image for Annals of the New York Academy of Sciences

May 1977

Volume 284 Third Conference on Antiviral Substances

Pages 1–720

    1. INTRODUCTORY REMARKS (pages 1–2)

      Ernest C. Herrmann Jr.

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21929.x

  1. Part I. Adenine Arabinoside

    1. Top of page
    2. Part I. Adenine Arabinoside
    3. Part II. Clinical Aspects
    4. Part III. Ribavirin
    5. Part IV. Newer Antiviral Substances
    6. Part V. Biochemical Studies
    7. Part VI. Abtiviral Agents and Tumor Viruses
    8. Part VII. Approaches to Discovery and Development of Antiviral Drugs
    9. Part VIII. Interieron Update
    1. INTRODUCTORY REMARKS ON ADENINE ARABINOSIDE (pages 3–5)

      William M Shannon

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21930.x

    2. COMPARATIVE ANIMAL TOXICOLOGY OF VIDARABINE AND ITS 5′-MONOPHOSPHATE (pages 6–8)

      S. M. Kurtz, J. E. Fitzgerald and J. L. Schardein

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21931.x

    3. INHIBITION OF ADENOSINE DEAMINASE BY CO-VIDARABINE AND ITS EFFECT ON THE METABOLIC DISPOSITION OF ADENINE ARABINOSIDE (VIDARABINE) (pages 9–20)

      P. E. Borondy, T. Chang, E. Maschewske and A. J. Glazko

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21932.x

    4. ISOLATION AND PROPERTIES OF A VIDARABINE DEAMINASE INHIBITOR, CO-VIDARABINE (pages 21–29)

      Henry W Dion, Peter W. K Woo and Albert Ryder

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21933.x

    5. A LABELED 9-β-D-ARABINOFURANOSYLADENINE 5'-MONOPHOSPHATE HAVING INCREASED METABOLIC STABILITY (pages 30–33)

      David C Baker and Theodore H Haskell

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21934.x

    6. INHIBITION OF HERPESVIRUS DNA SYNTHESIS BY 9-β-D-ARABINOFURANOSYLADENINE IN CELLULAR AND CELL-FREE SYSTEMS (pages 34–48)

      W. E. G. Müller, R. K. Zahn, K. Bittlingmaier and D. Falke

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21935.x

    7. RELATIVE POTENCIES OF ANTI-HERPES COMPOUNDS (pages 49–59)

      P. Collins and D. J. Bauer

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21936.x

    8. DISCUSSION (pages 103–105)

      W. B. Shannon

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21940.x

  2. Part II. Clinical Aspects

    1. Top of page
    2. Part I. Adenine Arabinoside
    3. Part II. Clinical Aspects
    4. Part III. Ribavirin
    5. Part IV. Newer Antiviral Substances
    6. Part V. Biochemical Studies
    7. Part VI. Abtiviral Agents and Tumor Viruses
    8. Part VII. Approaches to Discovery and Development of Antiviral Drugs
    9. Part VIII. Interieron Update
    1. SMALL AIRWAYS DYSFUNCTION IN INFLUENZA A VIRUS INFECTION: THERAPEUTIC ROLE AND POTENTIAL MODE OF ACTION OF AMANTADINE (pages 106–117)

      John W Little, William J Hall and R Gordon Douglas Jr.

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21941.x

    2. METHISAZONE THERAPY IN PEDIATRIC VACCINIA COMPLICATIONS (pages 118–121)

      Donald M. McLean

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21942.x

    3. THE MINI VIRAL DIAGNOSTIC LABORATORY–A NECESSARY ADJUNCT TO THE USE OF ANTIVIRAL DRUGS (pages 122–127)

      Judith A. Herrmann and Ernest C. Herrmann Jr.

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21943.x

    4. INOSIPLEX: AN IMMUNOMODULATION MODEL FOR THE TREATMENT OF VIRAL DISEASE (pages 128–138)

      Theodore Ginsberg and Alvin J. Glasky

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21944.x

    5. LEVAMISOLE AND INOSIPLEX: ANTIVIRAL AGENTS WITH IMMUNOPOTENTIATING ACTION (pages 139–152)

      John W Hadden, Carlos Lopez, Richard J O'Reilly and Elba M Hadden

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21945.x

    6. THERAPEUTIC EFFICACY OF INOSIPLEX (ISOPRINOSINE®) IN RHINOVIRUS INFECTION (pages 153–160)

      Robert H. Waldman and Rama Ganguly

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21946.x

    7. CORRELATION OF CLINICAL AND VIRUS-SPECIFIC IMMUNE RESPONSES FOLLOWING LEVAMISOLE THERAPY OF RECURRENT HERPES PROGENITALIS (pages 161–170)

      Richard J. O'Reilly, A. Chibbaro, R. Wilmot and C. Lopez

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21947.x

    8. PHOTODYNAMIC INACTIVATION OF HERPES SIMPLEX VIRUS: A STATUS REPORT (pages 171–181)

      Joseph L Melnick and Craig Wallis

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21948.x

    9. ANIMAL CORNEAS AS TOOLS FOR THE TESTING OF ANTIVIRAL COMPOUNDS (pages 182–189)

      M. Likar and M. Japelj

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21949.x

    10. IN VITRO STUDIES ON CELL-MEDIATED IMMUNITY IN PATIENTS TREATED WITH INOSIPLEX FOR HERPES VIRUS INFECTION (pages 190–196)

      L. Jack Bradshaw and Humphrey L. Sumner

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21950.x

    11. DISCUSSION (pages 197–200)

      E. C. Herrmann Jr.

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21951.x

  3. Part III. Ribavirin

    1. Top of page
    2. Part I. Adenine Arabinoside
    3. Part II. Clinical Aspects
    4. Part III. Ribavirin
    5. Part IV. Newer Antiviral Substances
    6. Part V. Biochemical Studies
    7. Part VI. Abtiviral Agents and Tumor Viruses
    8. Part VII. Approaches to Discovery and Development of Antiviral Drugs
    9. Part VIII. Interieron Update
    1. THE ENZYMIC CONVERSION OF 1,2,4-TRIAZOLE-3-CARBOXAMIDE TO RIBAVIRIN-5'-PHOSPHATE AND ITS RELATIONSHIP TO THE PROPOSED MECHANISM OF ACTION (pages 201–210)

      David G. Streeter, Jon P Miller, Roland K Robins and Lionel N Simon

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21952.x

    2. THE RELATIONSHIP BETWEEN THE METABOLISM OF RIBAVIRIN AND ITS PROPOSED MECHANISM OF ACTION (pages 211–229)

      Jon P. Miller, Linda J Kigwana, David G Streeter, Roland K Robins, Lionel N Simon and John Roboz

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21953.x

    3. IMMUNOSUPPRESSIVE ACTIVITY OF RIBAVIRIN USING THE RABBIT SKIN ALLOGRAFT MODEL (pages 230–232)

      Weldon B Jolley, Terry W Call, Lynn S Alvord and David B Hinshaw

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21954.x

    4. EFFECT OF RIBAVIRIN ON VIRAL HEPATITIS IN LABORATORY ANIMALS (pages 239–246)

      Robert W Sidwell, John H Huffman, Nancy Campbell and Lois B Allen

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21956.x

    5. EFFECT OF RIBAVIRIN ON TYPE 2 HERPESVIRUS HOMINIS (HVH/2) IN VITRO AND IN VIVO (pages 247–253)

      L. B. Allen, S. M. Wolf, C. J. Hintz, J. H. Huffman and R. W. Sidwell

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21957.x

    6. THE RELATIVE POTENCIES OF ANTI-INFLUENZA COMPOUNDS (pages 254–263)

      Margaret Tisdale and D. J. Bauer

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21958.x

    7. AEROSOL THERAPY OF INFLUENZA INFECTIONS OF MICE AND PRIMATES WITH RIMANTADINE, RIBAVIRIN, AND RELATED COMPOUNDS (pages 264–271)

      Edward L Stephen, Jerry S Walker, Joseph W Dominik, Harold W Young and Richard F Berendt

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21959.x

    8. CLINICAL EVALUATION OF 1-β-D-RIBOFURANOSYL-1,2,4-TRIAZOLE-3-CARBOXAMIDE (RIBAVIRIN) IN A DOUBLE-BLIND STUDY DURING AN OUTBREAK OF INFLUENZA (pages 272–277)

      Francisco Salido-Rengell, H. Nasser-Quinones and B. Briseno-Garcia

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21960.x

    9. THE EFFECT OF l-β-D-RIBOFURANOSYL-1,2,4-TRIAZOLE-3-CARBOXAMIDE ON ACUTE VIRAL HEPATITIS (pages 278–283)

      Paulo A Ayrosa-Galvão and Ivan O Castro

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21961.x

    10. CLINICAL EXPERIENCES USING THE ANTIVIRAL 1-β-D-RIBOFURANOSYL-1,2,4-TRIAZOLE-3-CARBOXAMIDE (RIBAVIRIN) IN MEXICO (pages 284–288)

      Humberto Fernandez Zertuche and R. Diaz Perches

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21962.x

    11. DISCUSSION (pages 289–293)

      C.E. Hoffmann

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21963.x

  4. Part IV. Newer Antiviral Substances

    1. Top of page
    2. Part I. Adenine Arabinoside
    3. Part II. Clinical Aspects
    4. Part III. Ribavirin
    5. Part IV. Newer Antiviral Substances
    6. Part V. Biochemical Studies
    7. Part VI. Abtiviral Agents and Tumor Viruses
    8. Part VII. Approaches to Discovery and Development of Antiviral Drugs
    9. Part VIII. Interieron Update
    1. SPECIFIC INHIBITION OF VIRUS MULTIPLICATION BY BICHLORINATED PYRIMIDINES (pages 294–304)

      Paolo La Colla, Maria A Marcialis, Ornella Flore, Mario Sau, Aldo Garzia and Bernardo Loddo

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21964.x

    2. A NEW ANTIRHINOVIRUS COMPOUND, ICI 73602: STRUCTURE, PROPERTIES, AND SPECTRUM OF ACTIVITY (pages 305–309)

      D. L. Swallow, R. A. Bucknall, W. E. Stanier, A. Hutchinson and H. Gaskin

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21965.x

    3. ANTIVIRAL POTENTIAL OF PHOSPHONOACETIC ACID (pages 310–320)

      L. R. Overby, R. G. Duff and J. C.-H. Mao

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21966.x

    4. RECENT STUDIES ON THE ANTIVIRAL AND BIOCHEMICAL PROPERTIES OF 5-HALO-5'-AMINO-DEOXYRIBONUCLEOSIDES (pages 335–341)

      W. H. Prusoff, D. C. Ward, T. S. Lin, M. S. Chen, G. T. Shaiu, C. Chai, E. Lentz, R. Capizzi, J. Idriss, N. H. Ruddle, F. L. Black, H. L. Kumari, D. Albert, P. N. Bhatt, S. Strickland, G. D. Hsiung and Y. C. Cheng

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21968.x

    5. ARABINOSYL-N6-HYDROXYADENINE: A NEW POTENT ANTIVIRUS DRUG (pages 351–357)

      Carlos Lopez and A. Giner-Sorolla

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21970.x

    6. ACTIVITY OF SOME FLAVONOIDS AGAINST VIRUSES (pages 358–364)

      I. Béládi, R. Pusztai, I. Mucsi, M. Bakay and M. Gábor

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21971.x

    7. DISCUSSION (pages 365–366)

      D. C. DeLong

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21972.x

  5. Part V. Biochemical Studies

    1. Top of page
    2. Part I. Adenine Arabinoside
    3. Part II. Clinical Aspects
    4. Part III. Ribavirin
    5. Part IV. Newer Antiviral Substances
    6. Part V. Biochemical Studies
    7. Part VI. Abtiviral Agents and Tumor Viruses
    8. Part VII. Approaches to Discovery and Development of Antiviral Drugs
    9. Part VIII. Interieron Update
    1. MECHANISM OF THE ANTIVIRAL ACTION OF BLEOMYCIN (pages 367–374)

      M. Takeshita, S. B. Horwitz and A. P. Grollman

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21973.x

    2. THE EFFECT OF CYCLIC NUCLEOTIDES ON VIRUS INFECTION (pages 375–388)

      H. F. Maassab and R. M. Soltysiak

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21974.x

    3. SELECTIVE INHIBITION OF THE REPLICATION OF VARICELLA-ZOSTER VIRUS BY 5-HALOGENATED ANALOGS OF DEOXYCYTIDINE (pages 389–395)

      Mary Ann Jerkofsky, Michael J Dobersen and Sheldon Greer

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21975.x

    4. ANTIVIRAL ACTION AND SELECTIVITY OF 6-AZAURIDINE (pages 410–417)

      Břetislav Rada and Marián Dragúň

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21977.x

    5. INHIBITION OF POLIOVIRUS REPLICATION BY A PLANT ANTIVIRAL PEPTIDE (pages 431–440)

      Michael A Ussery, James D Irvin and Boyd Hardesty

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21979.x

    6. DISCUSSION (pages 441–443)

      W. H. Prusoff

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21980.x

  6. Part VI. Abtiviral Agents and Tumor Viruses

    1. Top of page
    2. Part I. Adenine Arabinoside
    3. Part II. Clinical Aspects
    4. Part III. Ribavirin
    5. Part IV. Newer Antiviral Substances
    6. Part V. Biochemical Studies
    7. Part VI. Abtiviral Agents and Tumor Viruses
    8. Part VII. Approaches to Discovery and Development of Antiviral Drugs
    9. Part VIII. Interieron Update
    1. MOLECULAR APPROACHES TO INHIBIT ONCOGENESIS BY RNA TUMOR VIRUSES (pages 444–462)

      P. Chandra, U. Ebener, Linda K. Steel, H. Laube, D. Gericke, B. Mildner, T. J. Bardos, Y. K. Ho and A. Götz

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21981.x

    2. INACTIVATION AND INHIBITION OF ROUS SARCOMA VIRUS BY COPPER-BINDING LIGANDS: THIOSEMICARBAZONES, 8-HYDROXYQUINOLINES, AND ISONICOTINIC ACID HYDRAZIDE (pages 525–532)

      Warren Levinson, Wolfgang Rohde, Peter Mikelens, Jean Jackson, A. Antony and T. Ramakrishnan

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21985.x

    3. CONTACT INACTIVATION OF RNA AND DNA VIRUSES BY N-METHYL ISATIN BETA-THIOSEMICARBAZONE AND CuSO4 (pages 533–543)

      M. P. Fox, L. H. Bopp and C. J. Pfau

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21986.x

    4. INTERRUPTION OF ONCORNAVIRUS REPLICATION BY MODIFIED RIFAMYCIN ANTIBIOTICS (pages 544–565)

      Timothy E O'Connor, Charles D Aldrich and V. Sagar Sethi

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21987.x

    5. CONCEPTS ON THE INTERFERENCE OF REPLICATION AND EXPRESSION OF RNA TUMOR VIRUSES (pages 576–584)

      David Gillespie and Robert C Gallo

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21989.x

    6. ANTITUMOR EFFECTS OF RIBAVIRIN ON L1210 LEUKEMIA IN THE DBA-2 MOUSE (pages 585–590)

      Weldon B Jolley, William T Chu, James M Slater, David B Hinshaw and Ajit S Randhawa

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21990.x

    7. DISCUSSION (pages 591–593)

      J. L. Melnick

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21991.x

  7. Part VII. Approaches to Discovery and Development of Antiviral Drugs

    1. Top of page
    2. Part I. Adenine Arabinoside
    3. Part II. Clinical Aspects
    4. Part III. Ribavirin
    5. Part IV. Newer Antiviral Substances
    6. Part V. Biochemical Studies
    7. Part VI. Abtiviral Agents and Tumor Viruses
    8. Part VII. Approaches to Discovery and Development of Antiviral Drugs
    9. Part VIII. Interieron Update
    1. EVALUATION OF ANTIVIRAL COMPOUNDS: ACUTE VERSUS PERSISTENT INFECTIONS IN CELL CULTURES. (pages 599–603)

      W. Schwöbel and G. Streissle

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21993.x

    2. IONTOPHORETIC APPLICATION OF ANTIVIRAL CHEMOTHERAPEUTIC AGENTS (pages 604–612)

      J. M. Hill, L. P. Gangarosa and N. H. Park

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21994.x

    3. INFLUENZA RNA TRANSCRIPTASE INHIBITORS: STUDIES IN VITRO AND IN VIVO (pages 613–623)

      J. S. Oxford and D. D. Perrin

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21995.x

    4. CUTANEOUS HERPES SIMPLEX VIRUS INFECTION OF GUINEA PIGS AS A MODEL FOR ANTIVIRAL CHEMOTHERAPY (pages 624–631)

      T. W. Schafer, M. Lieberman, J. Everitt and P. Came

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21996.x

    5. A WORKING HYPOTHESIS—VIRUS RESISTANCE DEVELOPMENT AS AN INDICATOR OF SPECIFIC ANTIVIRAL ACTIVITY (pages 632–637)

      E. C. Herrmann Jr. and J. A. Herrmann

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21997.x

    6. INHIBITION OF INFLUENZA VIRUS BY TRIPHENYLMETHANE COMPOUNDS (pages 638–649)

      David L. Steward, Jack Martin and Arthur P. Grollman

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb21998.x

    7. DISCUSSION (pages 662–665)

      H. E. Kaufman

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb22000.x

  8. Part VIII. Interieron Update

    1. Top of page
    2. Part I. Adenine Arabinoside
    3. Part II. Clinical Aspects
    4. Part III. Ribavirin
    5. Part IV. Newer Antiviral Substances
    6. Part V. Biochemical Studies
    7. Part VI. Abtiviral Agents and Tumor Viruses
    8. Part VII. Approaches to Discovery and Development of Antiviral Drugs
    9. Part VIII. Interieron Update
    1. INTERFERON (page 666)

      Warren R. Stinebring

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb22001.x

    2. EFFECT OF AN INTERFERON INDUCER, 9-METHYLSTREPTIMIDONE, ON INFLUENZA VIRUS INFECTION IN MICE (pages 667–675)

      Fujio Suzuki, Noriyuki Saito and Nakao Ishida

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb22002.x

    3. ACCELERATION OF SCRAPIE IN MICE BY TARGET-ORGAN TREATMENT WITH INTERFERON INDUCERS (pages 676–681)

      Lois B. Allen and K. W. Cochran

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb22003.x

    4. IN VIVO ANTIVIRAL ACTIVITY OF POLYNUCLEOTIDE MIMICS OF STRATEGIC REGIONS IN VIRAL RNA (pages 682–696)

      N. Stebbing, C. A. Grantham, I. J. D. Lindley, M. A. W. Eaton and N. H. Carey

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb22004.x

    5. DE NOVO CELL-FREE SYNTHESIS OF HUMAN INTERFERON (pages 697–702)

      Sidney Pestka, James Mcinnes, David Weiss, Edward A Havell and Jan Vilček

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb22005.x

    6. ANTIGENIC, PHYSICOCHEMICAL, AND BIOLOGIC CHARACTERIZATION OF HUMAN INTERFERONS (pages 703–710)

      Jan Vilček, Edward A. Havell and Shudo Yamazaki

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb22006.x

    7. THE MECHANISM OF ACTION OF INTERFERON (pages 711–716)

      W. K. Joklik

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb22007.x

    8. DISCUSSION (pages 717–720)

      W. R. Stinebring

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1977.tb22008.x

SEARCH

SEARCH BY CITATION